Similarly, when 10 MPN patients all harboring the JAK2 p.V617F variant were studied by retrograde extrapolation, the development of a JAK2 mutation first was associated with an increased propensity toward PV or MF, whereas the development of a DNMT3A mutation first was associated with an increased propensity toward ET [69]. Here, JAK2 is linked to acquired polycythemia vera.